产品编号
|
产品描述
|
规格/包装
|
品牌
|
1135-RA-050
|
Recombinant Mouse Rae-1 epsilon/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1136-RA-050
|
Recombinant Mouse Rae-1 gamma/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1137-SL-050
|
Recombinant Human Siglec-3/CD33/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1138-SL-050
|
Recombinant Human Siglec-7/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1139-SL-050
|
Recombinant Human Siglec-9/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
113-BP-100
|
Recombinant Human BMP-3 (100 UG)
|
100 UG
|
R&D SYSTEMS
|
113-BP-100/CF
|
Recombinant Human BMP-3, CF (100 UG)
|
100 UG
|
R&D SYSTEMS
|
1141-PI-010
|
Recombinant Mouse HAI-1, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
11450-1
|
Recombinant Human IFN-kappa, CF
|
50 µg
|
R&D SYSTEMS
|
1145-RG-050
|
Recombinant Human RAGE/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1146-S6-025
|
Recombinant Human Semaphorin 6A/Fc Chimera, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1150-ML-020
|
Recombinant Mouse IL-2 (Cys 141 Ser) (20 UG)
|
20 UG
|
R&D SYSTEMS
|
1150-ML-020/CF
|
Recombinant Mouse IL-2 (Cys 141 Ser), CF (20 UG)
|
20 UG
|
R&D SYSTEMS
|
1151-CL-025
|
Recombinant Human CLF-1/CLC Complex (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1151-CL-025/CF
|
Recombinant Human CLF-1/CLC Complex, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1152-GA-050
|
Recombinant Human Galectin-1 (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1152-GA-050/CF
|
Recombinant Human Galectin-1, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1153-GA-050
|
Recombinant Human Galectin-2 (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1153-GA-050/CF
|
Recombinant Human Galectin-2, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1154-GA-050
|
Recombinant Human Galectin-3 (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1154-GA-050/CF
|
Recombinant Human Galectin-3, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1155-H6-050
|
Recombinant Mouse H60/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1156-NG-100
|
Recombinant Mouse beta-NGF (100 UG)
|
100 UG
|
R&D SYSTEMS
|
1156-NG-100/CF
|
Recombinant Mouse beta-NGF, CF (100 UG)
|
100 UG
|
R&D SYSTEMS
|
1157-NR-050
|
Recombinant Mouse NGF R/TNFRSF16/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1158-RA-050
|
Recombinant Mouse Rae-1 alpha/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1159-SB-025
|
Recombinant Human PDGF-DD (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1159-SB-025/CF
|
Recombinant Human PDGF-DD, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1160-A1-050
|
Recombinant Human Bcl-2 related protein A1 (aa 1-152), CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1161-LV-100
|
Recombinant Human Livin alpha/KIAP, CF (100 UG)
|
100 UG
|
R&D SYSTEMS
|
1162-BR-050
|
Recombinant Human BAFF R/TNFRSF13C/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1163-CL-025
|
Recombinant Mouse CD40 Ligand/TNFSF5 (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1163-CL-025/CF
|
Recombinant Mouse CD40 Ligand/TNFSF5, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1164-CX-025
|
Recombinant Human CXCL16 (Histidine-tagged) (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1164-CX-025/CF
|
Recombinant Human CXCL16 (Histidine-tagged), CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1165-CX-025
|
Recombinant Mouse CXCL16 (Histidine-tagged) (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1165-CX-025/CF
|
Recombinant Mouse CXCL16 (Histidine-tagged), CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1166-NG-025
|
Recombinant Mouse Netrin-G1a (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1166-NG-025/CF
|
Recombinant Mouse Netrin-G1a, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1167-PR-050
|
Recombinant Human Prolactin R/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1168-CR-050
|
Recombinant Human Ret (Histidine-tagged) (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1168-CR-050/CF
|
Recombinant Human Ret (Histidine-tagged), CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1169-FR-025
|
Recombinant Mouse sFRP-2 (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1169-FR-025/CF
|
Recombinant Mouse sFRP-2, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1172-AL-050
|
Recombinant Mouse ALCAM/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1173-M5-050
|
Recombinant Mouse ICAM-5/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1176-IR-050
|
Recombinant Human IL-20 R alpha/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1179-RG-050
|
Recombinant Mouse RAGE/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
117-VL-025
|
Recombinant Viral HCMV IL-10 (25 UG)
|
25 UG
|
R&D SYSTEMS
|
117-VL-025/CF
|
Recombinant Viral HCMV IL-10, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1180-SE-010
|
Recombinant Human DPPIV/CD26, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1182-ZN-010
|
Recombinant Human Neprilysin, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1183-CY-010
|
Recombinant Human Cathepsin S, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1184-PI-050
|
Recombinant Human Fetuin A/AHSG, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1187-TR-025
|
Recombinant Mouse TREM-1/Fc Chimera, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1189-J3-050
|
Recombinant Human JAM-C/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
118-AP-100
|
Recombinant Human IL-18 R beta/IL-1 R7/Fc Chimera, CF (100 UG)
|
100 UG
|
R&D SYSTEMS
|
1190-NT-050
|
Recombinant Rat Notch-2/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1195-EP-025
|
Recombinant Human Epiregulin (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1195-EP-025/CF
|
Recombinant Human Epiregulin, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1196-PI-010
|
Recombinant Human Cystatin C, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
11976-1
|
Thymosin alpha 1, CF
|
500 µg
|
R&D SYSTEMS
|
1197-GA-050
|
Recombinant Mouse Galectin-3 (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1197-GA-050/CF
|
Recombinant Mouse Galectin-3, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1198-RA-050
|
Recombinant Mouse Rae-1 beta/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1199-TW-050
|
Recombinant Human TWEAK R/TNFRSF12/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
119-BP-100
|
Recombinant Human IL-18 BPa/Fc Chimera, CF (100 UG)
|
100 UG
|
R&D SYSTEMS
|
1200-SE-010
|
Recombinant Mouse HGF Activator, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1201-PI-010
|
Recombinant Human Cystatin SA, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1202-PI-010
|
Recombinant Human Cystatin D, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1204-ML-025
|
Recombinant Mouse IL-20 (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1204-ML-025/CF
|
Recombinant Mouse IL-20, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1206-F3-025
|
Recombinant Human FGF-3 (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1206-F3-025/CF
|
Recombinant Human FGF-3, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1207-BR-050
|
Recombinant Human IL-17B R/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1208-NG-050
|
Recombinant Human Nogo Receptor/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1209-EV-025
|
Recombinant Human EG-VEGF/PK1 (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1209-EV-025/CF
|
Recombinant Human EG-VEGF/PK1, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
120-HD-001
|
Human PDGF, CF (1 UG)
|
1 UG
|
R&D SYSTEMS
|
120-HD-005
|
Human PDGF, CF (5 UG)
|
5 UG
|
R&D SYSTEMS
|
12105-1
|
Recombinant Mouse IFN-alpha 1
|
100000 U
|
R&D SYSTEMS
|
1210-GR-050
|
Recombinant Human Growth Hormone R (GHR)/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
12110-1
|
Recombinant Mouse IFN-alpha 4
|
100000 U
|
R&D SYSTEMS
|
1211-GR-050
|
Recombinant Rat Growth Hormone R (GHR)/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
12125-1
|
Recombinant Mouse IFN-alpha 11
|
100000 U
|
R&D SYSTEMS
|
1212-FG-025
|
Recombinant Human FGF-16 (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1212-FG-025/CF
|
Recombinant Human FGF-16, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
12130-1
|
Recombinant Mouse IFN-alpha 13
|
100000 U
|
R&D SYSTEMS
|
1213-J3-050
|
Recombinant Mouse JAM-C/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1214-B7-050
|
Recombinant Rat B7-1/CD80/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1215-CD-050
|
Recombinant Mouse CD40/TNFRSF5/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1220-PG-025
|
Recombinant Human Aggrecan G1-IGD-G2 Domains, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1224-PL-100
|
Recombinant Human PD-L2/Fc Chimera, CF (100 UG)
|
100 UG
|
R&D SYSTEMS
|
1227-GA-050
|
Recombinant Human Galectin-4 (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1227-GA-050/CF
|
Recombinant Human Galectin-4, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
122-BP-100
|
Recombinant Mouse IL-18BPd/Fc Chimera, CF (100 UG)
|
100 UG
|
R&D SYSTEMS
|
1234-IL-025
|
Recombinant Human IL-17C (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1234-IL-025/CF
|
Recombinant Human IL-17C, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1236-OX-025
|
Recombinant Mouse OX40 Ligand/TNFSF4 (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1236-OX-025/CF
|
Recombinant Mouse OX40 Ligand/TNFSF4, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1237-TW-025
|
Recombinant Mouse TWEAK/TNFSF12 (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1237-TW-025/CF
|
Recombinant Mouse TWEAK/TNFSF12, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1238-PI-010
|
Recombinant Mouse Cystatin C, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1239-PI-010
|
Recombinant Mouse Serpin F2/alpha 2-Antiplasmin, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
123-FE-050
|
Recombinant Human CD23/Fc epsilon RII, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1245-GA-050
|
Recombinant Mouse Galectin-1 (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1245-GA-050/CF
|
Recombinant Mouse Galectin-1, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1246-4L-025
|
Recombinant Mouse 4-1BB Ligand/TNFSF9 (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1246-4L-025/CF
|
Recombinant Mouse 4-1BB Ligand/TNFSF9, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1247-ZV-010
|
Recombinant Zebrafish VEGF 165 (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1247-ZV-010/CF
|
Recombinant Zebrafish VEGF 165, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1248-IB-025
|
Recombinant Human IL-17B (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1248-IB-025/CF
|
Recombinant Human IL-17B, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1250-S3-025
|
Recombinant Human Semaphorin 3A/Fc Chimera, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1254-N4-025
|
Recombinant Human Netrin-4 (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1254-N4-025/CF
|
Recombinant Human Netrin-4, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1255-F3-025
|
Recombinant Mouse FLRG (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1255-F3-025/CF
|
Recombinant Mouse FLRG, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1256-OX-050
|
Recombinant Mouse OX40/TNFRSF4/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1257-FC-050
|
Recombinant Human Fc gamma RIA/CD64, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1258-IL-025
|
Recombinant Human IL-17E (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1258-IL-025/CF
|
Recombinant Human IL-17E, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
125-PD-005
|
Porcine PDGF, CF (5 UG)
|
5 UG
|
R&D SYSTEMS
|
1264-FR-050
|
Recombinant Human FGF R3 (IIIb)/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1265-PI-010
|
Recombinant Mouse Serpin D1/Heparin Cofactor II, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1266-PI-010
|
Recombinant Human Serpin A5, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1267-PI-010
|
Recombinant Human Serpin C1/Antithrombin-III, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1268-PI-010
|
Recombinant Human Serpin A1, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1269-DK-010
|
Recombinant Human Dkk-4 (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1269-DK-010/CF
|
Recombinant Human Dkk-4, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
126-FL-010
|
Recombinant Human Fas Ligand/TNFSF6 (10 UG)
|
10 UG
|
R&D SYSTEMS
|
126-FL-010/CF
|
Recombinant Human Fas Ligand/TNFSF6, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1274-PI-100
|
Recombinant Human SLPI, CF (100 UG)
|
100 UG
|
R&D SYSTEMS
|
1275-IL-025
|
Recombinant Human IL-1F5/FIL1 delta (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1275-IL-025/CF
|
Recombinant Human IL-1F5/FIL1 delta, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1278-TR-050
|
Recombinant Human TREM-1/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
127-N2-025
|
Recombinant Chicken Netrin-2 (25 UG)
|
25 UG
|
R&D SYSTEMS
|
127-N2-025/CF
|
Recombinant Chicken Netrin-2, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1280-ER-050
|
Recombinant Mouse EGF R/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1284-PI-010
|
Recombinant Mouse Cystatin E/M, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1285-PI-010
|
Recombinant Human Cystatin SN, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1286-PI-010
|
Recombinant Human Cystatin E/M, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1287-PI-010
|
Recombinant Mouse Serpin C1/Antithrombin-III, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1288-F3-025
|
Recombinant Human FLRG (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1288-F3-025/CF
|
Recombinant Human FLRG, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
128-N1-025
|
Recombinant Chicken Netrin-1 (25 UG)
|
25 UG
|
R&D SYSTEMS
|
128-N1-025/CF
|
Recombinant Chicken Netrin-1, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1290-IL-010
|
Recombinant Human IL-23 (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1290-IL-010/CF
|
Recombinant Human IL-23, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1294-AS-010
|
Recombinant Human Cathepsin E, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1295-PI-010
|
Recombinant Human Serpin A3, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1296-PI-010
|
Recombinant Human Cystatin S, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1297-NE-025
|
Recombinant Human Neurturin (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1297-NE-025/CF
|
Recombinant Human Neurturin, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1298-UL-050
|
Recombinant Human ULBP-2/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1299-NK-050
|
Recombinant Human NKG2D/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1300-MA-050
|
Recombinant Human MICA/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1304-GA-050
|
Recombinant Mouse Galectin-7 (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1304-GA-050/CF
|
Recombinant Mouse Galectin-7, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1305-GA-050
|
Recombinant Human Galectin-8 (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1305-GA-050/CF
|
Recombinant Human Galectin-8, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1306-RE-010
|
Recombinant Rat Erythropoietin (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1306-RE-010/CF
|
Recombinant Rat Erythropoietin, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1307-FZ-050
|
Recombinant Mouse Frizzled-2/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1308-NT-050
|
Recombinant Mouse Notch-3/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1309-PR-050
|
Recombinant Mouse Prolactin R/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
130-MD-050
|
Recombinant Mouse MD-1 (50 UG)
|
50 UG
|
R&D SYSTEMS
|
130-MD-050/CF
|
Recombinant Mouse MD-1, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1310-SE-010
|
Recombinant Human u-Plasminogen Activator/Urokinase, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1314-SH-025
|
Recombinant Human Sonic Hedgehog, N-Terminus (Shh-N) (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1314-SH-025/CF
|
Recombinant Human Sonic Hedgehog, N-Terminus (Shh-N), CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1315-ND-025
|
Recombinant Mouse Nodal (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1315-ND-025/CF
|
Recombinant Mouse Nodal, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1316-RL-010
|
Recombinant Rat IL-22 (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1316-RL-010/CF
|
Recombinant Rat IL-22, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1317-TR-050
|
Recombinant Mouse Thrombopoietin R/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1318-RL-010
|
Recombinant Rhesus Macaque IL-1 beta/IL-1F2 (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1318-RL-010/CF
|
Recombinant Rhesus Macaque IL-1 beta/IL-1F2, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1319-TL-010
|
Recombinant Human TL1A/TNFSF15 (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1319-TL-010/CF
|
Recombinant Human TL1A/TNFSF15, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
131-M1-025
|
Recombinant Human CCL23/MPIF-1 (aa 46-120) (25 UG)
|
25 UG
|
R&D SYSTEMS
|
131-M1-025/CF
|
Recombinant Human CCL23/MPIF-1 (aa 46-120), CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1320-EN-025
|
Recombinant Mouse Endoglin/CD105/Fc Chimera, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1324-WN-002
|
Recombinant Mouse Wnt-3a (2 UG)
|
2 UG
|
R&D SYSTEMS
|
1325-BL-050
|
Recombinant Human BIM (Long Form), CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1328-PI-050
|
Recombinant E. coli Ecotin, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
132-FA-025
|
Bovine FGF acidic (25 UG)
|
25 UG
|
R&D SYSTEMS
|
132-FA-025/CF
|
Bovine FGF acidic, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1330-CD-050
|
Recombinant Human Fc gamma RIIA/CD32a (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1330-CD-050/CF
|
Recombinant Human Fc gamma RIIA/CD32a, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1334-B7-025
|
Recombinant Human IGFBP-rp1/IGFBP-7, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1335-IL-025
|
Recombinant Human IL-17F (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1335-IL-025/CF
|
Recombinant Human IL-17F, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1335-INS-025
|
Recombinant Human IL-17F (NSO-expressed) (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1335-INS-025/CF
|
Recombinant Human IL-17F (NSO-expressed), CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1339-GA-050
|
Recombinant Human Galectin-7 (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1339-GA-050/CF
|
Recombinant Human Galectin-7, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
133-FB-025
|
Bovine FGF basic (25 UG)
|
25 UG
|
R&D SYSTEMS
|
133-FB-025/CF
|
Bovine FGF basic, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1340-B2-050
|
Recombinant Rat B7-2/CD86/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1341-WF-050
|
Recombinant Human WIF-1 (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1341-WF-050/CF
|
Recombinant Human WIF-1, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1344-SE-010
|
Recombinant Human Kallikrein 3/PSA, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1346-SE-010
|
Recombinant Mouse Granzyme G, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1357-BR-050
|
Recombinant Mouse BAFF R/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1360-GR-050
|
Recombinant Mouse Growth Hormone R (GHR)/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1365-SE-010
|
Recombinant Mouse Granzyme D, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1366-PT-050
|
Recombinant Human PTP1B (aa 2-321), CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
136-AN-050
|
Recombinant Mouse Angiopoietin-like 3, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1375-IL-025
|
Recombinant Human IL-26/AK155 Monomer (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1375-IL-025/CF
|
Recombinant Human IL-26/AK155 Monomer, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1377-SE-010
|
Recombinant Human Granzyme H, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1378-RP-050
|
Recombinant Mouse RP105/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
137-PS-050
|
Recombinant Human P-Selectin/CD62P/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1380-UL-050
|
Recombinant Human ULBP-1/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1384-SF-025
|
Recombinant Human sFRP-1 (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1384-SF-025/CF
|
Recombinant Human sFRP-1, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1385-RT-050
|
Recombinant Human RELT/TNFRSF19L/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1388-NC-050
|
Recombinant Human N-Cadherin/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1389-D4-050
|
Recombinant Mouse DLL4 (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1389-D4-050/CF
|
Recombinant Mouse DLL4, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1390-ER-050
|
Recombinant Mouse Erythropoietin R/Fc, Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1394-NP-050
|
Recombinant Mouse Nope/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1395-KC-025
|
Recombinant Mouse KC (aa 29-96) (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1395-KC-025/CF
|
Recombinant Mouse KC (aa 29-96), CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1396-KN-050
|
Recombinant Human Kininostatin (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1396-KN-050/CF
|
Recombinant Human Kininostatin, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1397-B3-050
|
Recombinant Mouse B7-H3 (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1397-B3-050/CF
|
Recombinant Mouse B7-H3, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1398-TS-010
|
Recombinant Human TSLP (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1398-TS-010/CF
|
Recombinant Human TSLP, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1399-IL-025
|
Recombinant Mouse IL-17E (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1399-IL-025/CF
|
Recombinant Mouse IL-17E, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
139-NK-050
|
Recombinant Mouse NKG2D/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1400-IR-050
|
Recombinant Human IL-23 R/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1404-TC-050
|
Recombinant Mouse TrkC (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1404-TC-050/CF
|
Recombinant Mouse TrkC, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1405-UN-050
|
Recombinant Rat UNC5H1/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1406-ST-025
|
Recombinant Human SOST (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1406-ST-025/CF
|
Recombinant Human SOST, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1407-PI-050
|
Recombinant Human Cystatin A, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1408-PI-050
|
Recombinant Human Cystatin B, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1409-PI-050
|
Recombinant Mouse Cystatin B, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
140-B1-100
|
Recombinant Human B7-1/CD80/Fc Chimera, CF (100 UG)
|
100 UG
|
R&D SYSTEMS
|
1410-CR-050
|
Recombinant Human Cryptic (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1410-CR-050/CF
|
Recombinant Human Cryptic, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1413-FB-025
|
Recombinant Rat FGF-BP (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1413-FB-025/CF
|
Recombinant Rat FGF-BP, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
141-B2-100
|
Recombinant Human B7-2/CD86/Fc Chimera, CF (100 UG)
|
100 UG
|
R&D SYSTEMS
|
1429-UN-050
|
Recombinant Human UNC5H4/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
142-DC-100
|
Recombinant Human DcR3/TNFRSF6B/Fc Chimera, CF (100 UG)
|
100 UG
|
R&D SYSTEMS
|
1433-OP-050
|
Recombinant Human Osteopontin (OPN) (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1433-OP-050/CF
|
Recombinant Human Osteopontin (OPN), CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1437-CD-050
|
Recombinant Mouse CD83/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
143-DE-100
|
Recombinant Human Decorin, CF (100 UG)
|
100 UG
|
R&D SYSTEMS
|
1440-NG-050
|
Recombinant Mouse Nogo Receptor/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1445-PL-050
|
Recombinant Mouse Prolactin (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1445-PL-050/CF
|
Recombinant Mouse Prolactin, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1447-PC-025
|
Recombinant Mouse PDGF-CC (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1447-PC-025/CF
|
Recombinant Mouse PDGF-CC, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
144-DR-100
|
Recombinant Human DR6/TNFRSF21/Fc Chimera, CF (100 UG)
|
100 UG
|
R&D SYSTEMS
|
1454-ZN-010
|
Recombinant Mouse Kell, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1458-HT-100
|
Recombinant Human HTRA2/Omi, CF (100 UG)
|
100 UG
|
R&D SYSTEMS
|
1459-S4-050
|
Recombinant Mouse IGSF4, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
145-CR-010
|
Recombinant Human Cripto-1 (10 UG)
|
10 UG
|
R&D SYSTEMS
|
145-CR-010/CF
|
Recombinant Human Cripto-1, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1460-CD-050
|
Recombinant Mouse Fc gamma RIIB/CD32b, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
146-IR-100
|
Recombinant Human IL-13 R alpha 1/Fc Chimera, CF (100 UG)
|
100 UG
|
R&D SYSTEMS
|
1470-PI-010
|
Recombinant Human Serpin F2/alpha 2-Antiplasmin, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1473-SE-010
|
Recombinant Human Coagulation Factor II/Thrombin, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1476-TR-050
|
Recombinant Mouse TLR1, CF
|
50 µg
|
R&D SYSTEMS
|
1477-AR-050
|
Recombinant Mouse Activin RIB/ALK-4/Fc Chimera, CF
|
50 µg
|
R&D SYSTEMS
|
1479-TC-050
|
Recombinant Human TCCR/WSX-1/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
147-IR-100
|
Recombinant Human IL-15 R alpha/Fc Chimera, CF (100 UG)
|
100 UG
|
R&D SYSTEMS
|
1487-TR-050
|
Recombinant Human TLR3, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
148-BC-100
|
Recombinant Human BCAM/Fc Chimera, CF (100 UG)
|
100 UG
|
R&D SYSTEMS
|
1493-CD-050
|
Recombinant Human CD40/TNFRSF5/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1494-TB-025
|
Recombinant Mouse TrkB (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1494-TB-025/CF
|
Recombinant Mouse TrkB, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1503-SE-010
|
Recombinant Human Furin, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1504-IL-025
|
Recombinant Human IL-17D (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1504-IL-025/CF
|
Recombinant Human IL-17D, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1505-LR-025
|
Recombinant Human LRP-6/Fc Chimera, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1506-D4-050
|
Recombinant Human DLL4 (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1506-D4-050/CF
|
Recombinant Human DLL4, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1507-CT-025
|
Recombinant Canine TNF-alpha/TNFSF1A (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1507-CT-025/CF
|
Recombinant Canine TNF-alpha/TNFSF2, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1508-S1-025
|
Recombinant Mouse Soggy-1 (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1508-S1-025/CF
|
Recombinant Mouse Soggy-1, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1513-ZN-010
|
Recombinant Mouse ACE, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1514-SE-010
|
Recombinant Human HGF Activator, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1515-CY-010
|
Recombinant Mouse Cathepsin L, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1516-PI-050
|
Recombinant Mouse Cystatin/Stefin Homolog 2, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1517-UL-050
|
Recombinant Human ULBP-3/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1525-DC-050
|
Recombinant Mouse Dectin-2 alpha, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1529-TM-050
|
Recombinant Mouse TIM-3/Fc Chimera, CF
|
50 µg
|
R&D SYSTEMS
|
1529-TM-050
|
Recombinant Mouse TIM-3/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1530-TR-050
|
Recombinant Mouse TLR2, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1533-TR-050
|
Recombinant Mouse TLR6/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1534-LS-050
|
Recombinant Rat L-Selectin/CD62L/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1535-LM-010
|
Recombinant Mouse Limitin (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1535-LM-010/CF
|
Recombinant Mouse Limitin, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1538-CR-010
|
Recombinant Mouse Cripto (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1538-CR-010/CF
|
Recombinant Mouse Cripto, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1539-PG-025
|
Recombinant Mouse GDF-8 Propeptide (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1539-PG-025/CF
|
Recombinant Mouse GDF-8 Propeptide, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1543-BP-025
|
Recombinant Human BMP-3b/GDF-10 (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1543-BP-025/CF
|
Recombinant Human BMP-3b/GDF-10, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1544-IR-050
|
Recombinant Human Insulin R/CD220 (aa 28-956) (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1544-IR-050/CF
|
Recombinant Human Insulin R/CD220 (aa 28-956), CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1545-RA-025
|
Recombinant Rat IL-1ra/IL-1F3 (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1545-RA-025/CF
|
Recombinant Rat IL-1ra/IL-1F3, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1546-GM-025
|
Recombinant Canine GM-CSF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1546-GM-025/CF
|
Recombinant Canine GM-CSF, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1548-TR-100
|
Recombinant Human TROY/TNFRSF19/Fc Chimera, CF (100 UG)
|
100 UG
|
R&D SYSTEMS
|
1549-S1-025
|
Recombinant Human Soggy-1 (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1549-S1-025/CF
|
Recombinant Human Soggy-1, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
154-AL-100
|
Recombinant Human Axl/Fc Chimera, CF (100 UG)
|
100 UG
|
R&D SYSTEMS
|
1559-NT-050
|
Recombinant Human Notch-3 (aa 40-467)/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1563-PI-050
|
Recombinant Mouse Fetuin A/AHSG, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1564-LX-050
|
Recombinant Mouse LOX-1, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1568-HP-050
|
Recombinant Mouse Hip (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1568-HP-050/CF
|
Recombinant Mouse Hip, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1569-PI-010
|
Recombinant Human Kininogen HMW (HKa), CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
156-B7-100
|
Recombinant Human B7-H1/Fc Chimera, CF (100 UG)
|
100 UG
|
R&D SYSTEMS
|
1577-IL-010
|
Recombinant Rhesus Macaque IL-4 (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1577-IL-010/CF
|
Recombinant Rhesus Macaque IL-4, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1578-HC-025
|
Recombinant Human CCL14a/HCC-1 (aa 28-93) (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1578-HC-025/CF
|
Recombinant Human CCL14a/HCC-1 (aa 28-93), CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
157-ER-100
|
Recombinant Human EDAR/Fc Chimera, CF (100 UG)
|
100 UG
|
R&D SYSTEMS
|
1580-HS-050
|
Recombinant Human HSP27, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1585-SE-010
|
Recombinant Human Enteropeptidase/Enterokinase, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1586-HG-025
|
Recombinant Equine IFN-gamma (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1586-HG-025/CF
|
Recombinant Equine IFN-gamma, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1587-IL-025
|
Recombinant Human IL-28A/IFN-lambda 2 (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1587-IL-025/CF
|
Recombinant Human IL-28A/IFN-lambda 2, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1588-B1-025
|
Recombinant Mouse IGFBP-1, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1589-ST-025
|
Recombinant Mouse SOST (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1589-ST-025/CF
|
Recombinant Mouse SOST, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
158-B7-100
|
Recombinant Mouse B7-H2/Fc Chimera, CF (100 UG)
|
100 UG
|
R&D SYSTEMS
|
1595-SE-010
|
Recombinant Human Kallikrein 11, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1596-B1-200
|
Recombinant Rat EphB1/Fc Chimera, CF (200 UG)
|
200 UG
|
R&D SYSTEMS
|
1597-FC-050
|
Recombinant Human Fc gamma RIIIB/CD16b (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1597-FC-050/CF
|
Recombinant Human Fc gamma RIIIB/CD16b, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1598-IL-025
|
Recombinant Human IL-29/IFN-lambda 1 (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1598-IL-025/CF
|
Recombinant Human IL-29/IFN-lambda 1, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1599-MB-050
|
Recombinant Human MICB (aa 23-298)/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
159-DP-020
|
Recombinant Drosophila Decapentaplegic (Dpp) (20 UG)
|
20 UG
|
R&D SYSTEMS
|
159-DP-020/CF
|
Recombinant Drosophila Decapentaplegic (Dpp) , CF (20 UG)
|
20 UG
|
R&D SYSTEMS
|
1600-R2-050
|
Recombinant Mouse TGF-beta RII/(mouse) Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1603-CV-010
|
Recombinant Canine VEGF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1603-CV-010/CF
|
Recombinant Canine VEGF, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1604-MK-010
|
Recombinant Human Active MKK6, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1605-IL-010
|
Recombinant Equine IL-10 (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1605-IL-010/CF
|
Recombinant Equine IL-10, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1607-CD-050
|
Recombinant Human CD163, CF
|
50 µg
|
R&D SYSTEMS
|
1608-CL-025
|
Recombinant Canine CXCL8/IL-8 (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1608-CL-025/CF
|
Recombinant Canine CXCL8/IL-8, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1609-CL-025
|
Recombinant Canine IL-6 (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1609-CL-025/CF
|
Recombinant Canine IL-6, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1610-TW-050
|
Recombinant Mouse TWEAK R/TNFRSF12/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1613-IL-020
|
Recombinant Equine IL-2 (Cys 141 Ser) (20 UG)
|
20 UG
|
R&D SYSTEMS
|
1613-IL-020/CF
|
Recombinant Equine IL-2 (Cys 141 Ser), CF (20 UG)
|
20 UG
|
R&D SYSTEMS
|
1614-FL-025
|
Recombinant Rat Fas Ligand/TNFSF6 (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1614-FL-025/CF
|
Recombinant Rat Fas Ligand/TNFSF6, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1616-RG-050
|
Recombinant Rat RAGE/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1617-FZ-050
|
Recombinant Human Frizzled-5/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1618-MR-050
|
Recombinant Rat MIS RII/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
161-DC-050
|
Recombinant Human DC-SIGN/CD209/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1627-WS-050
|
Recombinant Human WISP-1/CCN4, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1628-ZN-020
|
Recombinant E. coli Methionine Aminopeptidase/METAP, CF (20 UG)
|
20 UG
|
R&D SYSTEMS
|
162-D2-050
|
Recombinant Human DC-SIGNR/CD299/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1635-T2-050
|
Recombinant Human Thrombospondin-2, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1640-NV-050
|
Recombinant Human NOV/CCN3, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1645-ZN-010
|
Recombinant Human ECE-2, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1647-KR-025
|
Recombinant Mouse Kremen-1 (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1647-KR-025/CF
|
Recombinant Mouse Kremen-1, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1648-CB-050
|
Recombinant Human CDC25A (aa 336-524), CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1649-CD-050
|
Recombinant Human CDC25B (aa 377-566), CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1654-VH-050
|
Recombinant Human VHR, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
165-B7-100
|
Recombinant Human B7-H2/Fc Chimera, CF (100 UG)
|
100 UG
|
R&D SYSTEMS
|
1667-SE-010
|
Recombinant Human Tryptase gamma-1/TPSG1, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1668-ZN-020
|
Recombinant Human Pappalysin-2/PAPP-A2, CF (20 UG)
|
20 UG
|
R&D SYSTEMS
|
1669-PI-020
|
Recombinant Human Serpin A4/Kallistatin, CF (20 UG)
|
20 UG
|
R&D SYSTEMS
|
1670-SE-020
|
Recombinant E. coli HTRA/Protease Do, CF (20 UG)
|
20 UG
|
R&D SYSTEMS
|
1673-OM-025
|
Recombinant Human OMgp, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1674-MG-025
|
Recombinant Mouse OMgp, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1680-WS-050
|
Recombinant Mouse WISP-1/CCN4, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1686-MR-050
|
Recombinant Mouse IL-23 R/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1687-CC-025
|
Recombinant Human PDGF-CC (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1687-CC-025/CF
|
Recombinant Human PDGF-CC, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1688-AC-025
|
Recombinant Human gAdiponectin/gAcrp30, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1689-CD-050
|
Recombinant Human CD58/LFA-3 (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1689-CD-050/CF
|
Recombinant Human CD58/LFA-3, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
168-CS-100
|
Recombinant Mouse ICOS/Fc Chimera, CF (100 UG)
|
100 UG
|
R&D SYSTEMS
|
1690-HM-025
|
Recombinant Human HMGB1, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1695-CR-050
|
Recombinant Human CRTAM/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
169-CS-050
|
Recombinant Human ICOS/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1705-HH-025
|
Recombinant Mouse Indian Hedgehog (C28II) N-Terminus (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1705-HH-025/CF
|
Recombinant Mouse Indian Hedgehog (C28II) N-Terminus, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1706-SF-050
|
Recombinant Mouse Siglec-F/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1707-CR-200
|
Recombinant Human C-Reactive Protein (200 UG)
|
200 UG
|
R&D SYSTEMS
|
1707-CR-200/CF
|
Recombinant Human C-Reactive Protein, CF (200 UG)
|
200 UG
|
R&D SYSTEMS
|
1708-PI-050
|
Recombinant Human Lipocalin-1, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1709-ML-025
|
Recombinant Mouse IL-17B (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1709-ML-025/CF
|
Recombinant Mouse IL-17B, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1710-PI-050
|
Recombinant Mouse Cystatin/Stefin Homolog, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1714-CN-025
|
Recombinant Human Contactin-2/TAG1, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1719-SE-010
|
Recombinant Human Kallikrein 4/Prostase, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1720-DM-50
|
Recombinant Human Desmoglein-3/Fc Chimera, CF
|
50 µg
|
R&D SYSTEMS
|
1724-SE-020
|
Recombinant Human Complement MASP3 Catalytic Domain, CF (20 UG)
|
20 UG
|
R&D SYSTEMS
|
1725-PI-050
|
Recombinant Human Fetuin B, CF
|
50 µg
|
R&D SYSTEMS
|
1729-T2-050
|
Recombinant Mouse TREM-2b/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1737-MS-010
|
Recombinant Human MIS/AMH (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1737-MS-010/CF
|
Recombinant Human MIS/AMH, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1744-CR-200
|
Recombinant Rat C-Reactive Protein (200 UG)
|
200 UG
|
R&D SYSTEMS
|
1744-CR-200/CF
|
Recombinant Rat C-Reactive Protein, CF (200 UG)
|
200 UG
|
R&D SYSTEMS
|
1747-PI-010
|
Recombinant Human Trappin-2/Elafin, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1749-RB-050
|
Recombinant Rat ROBO1/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
174-TC-050
|
Recombinant Human TACI/TNFRSF13B/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1750-TM-050
|
Recombinant Human TIM-1/KIM-1/HAVCR, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1756-DC-050
|
Recombinant Mouse Dectin-1/CLEC7A, CF
|
50 µg
|
R&D SYSTEMS
|
1756-DC-050
|
Recombinant Mouse Dectin-1/CLEC7A, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1757-LC-050
|
Recombinant Human Lipocalin-2/NGAL, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
175-TK-050
|
Recombinant Human TrkA/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1760-RL-010
|
Recombinant Rat IL-12 (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1760-RL-010/CF
|
Recombinant Rat IL-12, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1764-KR-025
|
Recombinant Mouse Kremen-2 (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1764-KR-025/CF
|
Recombinant Mouse Kremen-2, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1765-DK-010
|
Recombinant Mouse Dkk-1 (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1765-DK-010/CF
|
Recombinant Mouse Dkk-1, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
176-GB-025
|
Recombinant Human CXCL2/GRO beta (aa 39 - 107) (25 UG)
|
25 UG
|
R&D SYSTEMS
|
176-GB-025/CF
|
Recombinant Human CXCL2/GRO beta (aa 39 - 107), CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1774-MC-025
|
Recombinant Canine CCL2/MCP-1 (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1774-MC-025/CF
|
Recombinant Canine CCL2/MCP-1, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
177-IR-100
|
Recombinant Human IL-17 R/Fc Chimera, CF (100 UG)
|
100 UG
|
R&D SYSTEMS
|
1784-ZN-010
|
Recombinant Human ECE-1, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1785-MP-010
|
Recombinant Human MMP-16/MT3-MMP, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1786-PI-010
|
Recombinant Human Serpin E1/PAI-1, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1787-MD-050
|
Recombinant Human MD-2 (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1787-MD-050/CF
|
Recombinant Human MD-2, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1788-IR-050
|
Recombinant Human IL-20 R beta/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1789-ML-025
|
Recombinant Mouse IL-28B/IFN-lambda 3 (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1789-ML-025/CF
|
Recombinant Mouse IL-28B/IFN-lambda 3, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1790-CA-050
|
Recombinant Human Cadherin-11 (CAD-11)/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1794-LT-025
|
Recombinant Mouse LIGHT/TNFSF14 (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1794-LT-025/CF
|
Recombinant Mouse LIGHT/TNFSF14, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1795-FL-010
|
Recombinant Feline IL-5 (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1795-FL-010/CF
|
Recombinant Feline IL-5, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1796-FL-010
|
Recombinant Feline IL-1 beta/IL-1F2 (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1796-FL-010/CF
|
Recombinant Feline IL-1 beta/IL-1F2, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1797-MS-050
|
Recombinant Mouse SR-AI/MSR1, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1798-LX-050
|
Recombinant Human LOX-1, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1806-P3-010
|
Recombinant Human Active p38 alpha, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1807-SE-010
|
Recombinant Human Complement Component C1r, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1808-NR-050
|
Recombinant Human Chordin-Like 1 (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1808-NR-050/CF
|
Recombinant Human Chordin-Like 1, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1809-EL-020
|
Recombinant Equine IL-4 (20 UG)
|
20 UG
|
R&D SYSTEMS
|
1809-EL-020/CF
|
Recombinant Equine IL-4, CF (20 UG)
|
20 UG
|
R&D SYSTEMS
|
1810-EC-050
|
Recombinant Human Endocan (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1810-EC-050/CF
|
Recombinant Human Endocan, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1814-ET-025
|
Recombinant Equine TNF-alpha/TNFSF1A (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1814-ET-025/CF
|
Recombinant Equine TNF-alpha/TNFSF1A, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1815-CL-020
|
Recombinant Canine IL-2 (20 UG)
|
20 UG
|
R&D SYSTEMS
|
1815-CL-020/CF
|
Recombinant Canine IL-2, CF (20 UG)
|
20 UG
|
R&D SYSTEMS
|
1816-DT-050
|
Recombinant Mouse DcTRAIL R2/TNFRSF22 (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1816-DT-050/CF
|
Recombinant Mouse DcTRAIL R2/TNFRSF22, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1817-TM-050
|
Recombinant Mouse TIM-1/KIM-1/HAVCR (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1817-TM-050/CF
|
Recombinant Mouse TIM-1/KIM-1/HAVCR, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1819-KL-050
|
Recombinant Mouse Klotho (aa 35-982), CF
|
50 µg
|
R&D SYSTEMS
|
1824-SE-010
|
Recombinant Human Complement Factor D, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1826-TS-025
|
Recombinant Human Pentraxin 3/TSG-14 (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1826-TS-025/CF
|
Recombinant Human Pentraxin 3/TSG-14, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1827-SF-025
|
Recombinant Human sFRP-4 (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1827-SF-025/CF
|
Recombinant Human sFRP-4, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1829-CR-200
|
Recombinant Mouse C-Reactive Protein, CF (200 UG)
|
200 UG
|
R&D SYSTEMS
|
1830-SR-025
|
Recombinant Mouse IL-6 R (aa 20-357) (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1830-SR-025/CF
|
Recombinant Mouse IL-6 R (aa 20-357), CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1836-SR-050
|
Recombinant Mouse SIGNR1/CD209b/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1845-SH-025
|
Recombinant Human Sonic Hedgehog (C24II) N-Terminus (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1845-SH-025/CF
|
Recombinant Human Sonic Hedgehog (C24II) N-Terminus, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1849-NK-025
|
Recombinant Human NKp30/Fc Chimera, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1850-NK-025
|
Recombinant Human NKp46/NCR1/Fc Chimera, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1855-CD-050
|
Recombinant Human CD84/SLAMF5 (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1855-CD-050/CF
|
Recombinant Human CD84/SLAMF5, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1857-LC-050
|
Recombinant Mouse Lipocalin-2/NGAL, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1859-DC-050
|
Recombinant Human Dectin-1/CLEC7A,CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
185-OS-025
|
Recombinant Human Osteoprotegerin/TNFRSF11B (25 UG)
|
25 UG
|
R&D SYSTEMS
|
185-OS-025/CF
|
Recombinant Human Osteoprotegerin/TNFRSF11B, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1865-SE-010
|
Recombinant Mouse Granzyme B, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1869-HP-025
|
Recombinant Human HPRG, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1870-IL-010
|
Recombinant Human IL-26/AK155 Dimer (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1870-IL-010/CF
|
Recombinant Human IL-26/AK155 Dimer, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1875-CD-050
|
Recombinant Human FC gamma RIIB/C (CD32b/c), CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1878-SH-010
|
Recombinant Human Active SHP-1 (aa 205-595), CF
|
10 µg
|
R&D SYSTEMS
|
1886-EL-025
|
Recombinant Equine IL-6 (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1886-EL-025/CF
|
Recombinant Equine IL-6, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1887-ML-010
|
Recombinant Mouse IL-23 (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1887-ML-010/CF
|
Recombinant Mouse IL-23, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1888-LM-050
|
Recombinant Mouse LIMPII/SR-B2/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1889-PI-010
|
Recombinant Human Cystatin F, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
188-C8-005
|
Recombinant Human Cadherin-8 (CAD-8)/Fc Chimera, CF (5 UG)
|
5 UG
|
R&D SYSTEMS
|
1890-FL-020
|
Recombinant Feline IL-2 (20 UG)
|
20 UG
|
R&D SYSTEMS
|
1890-FL-020/CF
|
Recombinant Feline IL-2, CF (20 UG)
|
20 UG
|
R&D SYSTEMS
|
1894-SH-100
|
Recombinant Human Active SHP-2, CF
|
100 µg
|
R&D SYSTEMS
|
1894-SH-100
|
Recombinant Human Active SHP-2, CF
|
100 µg
|
R&D SYSTEMS
|
1895-SA-050
|
Recombinant Rat Pentraxin 2/SAP (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1895-SA-050/CF
|
Recombinant Rat Pentraxin 2/SAP, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1896-TL-010
|
Recombinant Mouse TL1A/TNFSF15 (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1896-TL-010/CF
|
Recombinant Mouse TL1A/TNFSF15, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1898-CD-050
|
Recombinant Human CD229/SLAMF3, CF
|
50 µg
|
R&D SYSTEMS
|
1905-HP-025
|
Recombinant Mouse HPRG, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1907-BL-050
|
Recombinant Human BLAME/SLAMF8, CF
|
50 µg
|
R&D SYSTEMS
|
1907-BL-050
|
Recombinant Human BLAME/SLAMF8, CF
|
50 µg
|
R&D SYSTEMS
|
1908-NT-050
|
Recombinant Human NTB-A/SLAMF6/Fc Chimera, CF
|
50 µg
|
R&D SYSTEMS
|
1915-MF-050
|
Recombinant Human MFRP, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1918-FN-02M
|
Human Fibronectin, CF (2 MG)
|
2 MG
|
R&D SYSTEMS
|
191-ED-010
|
Recombinant Mouse Ectodysplasin (EDA) (10 UG)
|
10 UG
|
R&D SYSTEMS
|
191-ED-010/CF
|
Recombinant Mouse Ectodysplasin (Eda), CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1920-SP-050
|
Recombinant Human SP-D, CF
|
50 µg
|
R&D SYSTEMS
|
1920-SP-050
|
Recombinant Human SP-D, CF
|
50 µg
|
R&D SYSTEMS
|
1927-ZN-010
|
Recombinant Human BMP-1/PCP, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1928-SE-010
|
Recombinant Mouse Spinesin, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
192-SF-010
|
Recombinant Human sFRP-3 (10 UG)
|
10 UG
|
R&D SYSTEMS
|
192-SF-010/CF
|
Recombinant Human sFRP-3, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1930-PT-050
|
Recombinant Human TC-PTP (aa 2-314), CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1934-DP-010
|
Recombinant Human DEP-1/CD148 (aa 997-1337), CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1936-SE-010
|
Recombinant Human Complement Component C2, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1937-SE-010
|
Recombinant Mouse Tryptase beta-1/MCPT-7, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1938-PI-050
|
Human alpha-2-Macroglobulin, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1939-SE-200
|
Human Plasminogen, CF (200 UG)
|
200 UG
|
R&D SYSTEMS
|
193-BC-050
|
Recombinant Human BCMA/TNFRSF17/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1945-RL-025
|
Recombinant Rat IL-13 (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1945-RL-025/CF
|
Recombinant Rat IL-13, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1946-KR-025
|
Recombinant Human Kremen-2 (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1946-KR-025/CF
|
Recombinant Human Kremen-2, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1947-MS-050
|
Recombinant Human MSP R/Ron, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1948-SA-050
|
Recombinant Human Pentraxin 2/SAP (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1948-SA-050/CF
|
Recombinant Human Pentraxin 2/SAP, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1949-B3-050
|
Recombinant Human B7-H3 (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1949-B3-050/CF
|
Recombinant Human B7-H3, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
194-FZ-050
|
Recombinant Mouse Frizzled-4/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1950-M5-050
|
Recombinant Human ICAM-5/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1954-FL-025
|
Recombinant Feline IL-12 (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1954-FL-025/CF
|
Recombinant Feline IL-12, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1955-CD-050
|
Recombinant Human CD36/SR-B3/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1956-CV-050
|
Recombinant Human Crossveinless-2 (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1956-CV-050/CF
|
Recombinant Human Crossveinless-2, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1957-KG-025
|
Recombinant Canine KGF/FGF-7 (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1957-KG-025/CF
|
Recombinant Canine KGF/FGF-7, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1958-GD-010
|
Recombinant Human GDF-11/BMP-11 (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1958-GD-010/CF
|
Recombinant Human GDF-11/BMP-11, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1959-B2-050
|
Recombinant Human IL-12 R beta 2/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1960-FC-050
|
Recombinant Mouse Fc gamma RIII/CD16, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1964-CL-025
|
Recombinant Canine IL-5 (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1964-CL-025/CF
|
Recombinant Canine IL-5, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1965-IL-025
|
Recombinant Human IL-24 (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1965-IL-025/CF
|
Recombinant Human IL-24, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1966-LM-050
|
Recombinant Human LIMPII/SR-B2/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1967-NG-025/CF
|
Recombinant Mouse Noggin, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1968-SL-050
|
Recombinant Human Siglec-2/CD22/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1969-CL-025
|
Recombinant Canine IL-12/IL-23 p40 (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1969-CL-025/CF
|
Recombinant Canine IL-12/IL-23 p40, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1970-TX-500
|
Recombinant Human Thioredoxin-1, CF (500 UG)
|
500 UG
|
R&D SYSTEMS
|
1974-CD-050
|
Recombinant Mouse Fcrl3/CD16-2, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1975-IL-025
|
Recombinant Human IL-1F7/FIL1 zeta, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1976-NV-050
|
Recombinant Mouse NOV/CCN3, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1977-MR-050
|
Recombinant Human IL-11 R alpha/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1978-MF-025
|
Recombinant Mouse MIF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1978-MF-025/CF
|
Recombinant Mouse MIF, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
1988-SE-010
|
Recombinant Human Marapsin/Pancreasin, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
1989-SE-010
|
Recombinant Mouse Marapsin/Pancreasin, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
198-FZ-050
|
Recombinant Mouse Frizzled-7/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1998-B1-050
|
Recombinant Mouse IL-12 R beta 1, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
1999-EC-050
|
Recombinant Mouse Endocan, CF
|
50 µg
|
R&D SYSTEMS
|
2009-CD-050
|
Recombinant Human CD55/DAF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
2009-CD-050/CF
|
Recombinant Human CD55/DAF, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
200-LA-002
|
Recombinant Human IL-1 alpha/IL-1F1 (2 UG)
|
2 UG
|
R&D SYSTEMS
|
200-LA-002/CF
|
Recombinant Human IL-1 alpha/IL-1F1, CF (2 UG)
|
2 UG
|
R&D SYSTEMS
|
200-LA-010
|
Recombinant Human IL-1 alpha/IL-1F1 (10 UG)
|
10 UG
|
R&D SYSTEMS
|
200-LA-010/CF
|
Recombinant Human IL-1 alpha/IL-1F1, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
2017-T2-050
|
Recombinant Human ILT2/CD85/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
201-LB-005
|
Recombinant Human IL-1 beta/IL-1F2 (5 UG)
|
5 UG
|
R&D SYSTEMS
|
201-LB-005/CF
|
Recombinant Human IL-1 beta/IL-1F2, CF (5 UG)
|
5 UG
|
R&D SYSTEMS
|
201-LB-025
|
Recombinant Human IL-1 beta/IL-1F2 (25 UG)
|
25 UG
|
R&D SYSTEMS
|
201-LB-025/CF
|
Recombinant Human IL-1 beta/IL-1F2, CF (25 UG)
|
25 UG
|
R&D SYSTEMS
|
2025-SE-010
|
Recombinant Human Kallikrein 8/Neuropsin, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
2026-EM-050
|
Recombinant Mouse Pro-EMAP-II, CF
|
50 µg
|
R&D SYSTEMS
|
2026-EM-050
|
Recombinant Mouse Pro-EMAP-II, CF
|
50 µg
|
R&D SYSTEMS
|
2028-EG-200
|
Recombinant Mouse EGF, CF (200 UG)
|
200 UG
|
R&D SYSTEMS
|
202-IL-010/CF
|
Recombinant Human IL-2, CF (10 UG)
|
10 UG
|
R&D SYSTEMS
|
202-IL-050/CF
|
Recombinant Human IL-2, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
2034-NR-050
|
Recombinant Human NrCAM/Fc Chimera, CF (50 UG)
|
50 UG
|
R&D SYSTEMS
|
2036-BC-050
|
Recombinant Human BOC, CF
|
50 µg
|
R&D SYSTEMS
|
2037-C5-025
|
Recombinant Human Complement Component C5a (25 UG)
|
25 UG
|
R&D SYSTEMS
|